BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16825431)

  • 1. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
    Alter BP; Rosenberg PS; Brody LC
    J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
    Degrolard-Courcet E; Sokolowska J; Padeano MM; Guiu S; Bronner M; Chery C; Coron F; Lepage C; Chapusot C; Loustalot C; Jouve JL; Hatem C; Ferrant E; Martin L; Coutant C; Baurand A; Couillault G; Delignette A; El Chehadeh S; Lizard S; Arnould L; Fumoleau P; Callier P; Mugneret F; Philippe C; Frebourg T; Jonveaux P; Faivre L
    Eur J Hum Genet; 2014 Aug; 22(8):979-87. PubMed ID: 24301060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
    Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
    Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between FANCD1/BRCA2 mutations and leukaemia.
    Alter BP
    Br J Haematol; 2006 May; 133(4):446-8; author reply 448. PubMed ID: 16643458
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia.
    Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N
    Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
    Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
    Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
    Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
    Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
    Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
    Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
    Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
    Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.
    Thirthagiri E; Klarmann KD; Shukla AK; Southon E; Biswas K; Martin BK; North SL; Magidson V; Burkett S; Haines DC; Noer K; Matthai R; Tessarollo L; Loncarek J; Keller JR; Sharan SK
    Hum Mol Genet; 2016 May; 25(10):1934-1945. PubMed ID: 26920070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
    Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
    Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics.
    Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q
    Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
    Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
    Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.